MarketInOut Stock Screener Log In | Sign Up

Concord Drugs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Concord Drugs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization896.69 mln
Float4.31 mln

EPS

1.67
Stretched

P / E

37.78
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-0.87
Highly suspicious

Relative Strength

15 / 100
Significantly lagging

Debt / Equity

0.28
Very low leverage

Business Description

Founded in 1995 and headquartered in Hyderabad, Concord Drugs Limited is an Indian pharmaceutical company that produces and sells a wide range of medical products. Its portfolio includes tissue adhesives, specialized pellet systems used in drug delivery, and everyday medicines available as tablets, capsules, injections, powders, and syrups. The company also manufactures hand sanitizers.

Key Fundamentals

EPS1.67
P/E37.78
ROE5.26
RPS72.15
ROIC5.33
ROA2.95
Interest Cover2.77
EBITDA, mln58.28
EV / EBITDA19.38
EV / EBIT25.21
Revenue, mln861
EV / Revenue1.32

Quote Details

Last 63.10
Change -1.92 (-2.95%)
Open 69.00
Volume 5,482
Turnover 345,914
Average Volume 4,001.48

Financial Ratios

Pre-Tax Profit Margin3
Current Ratio2.53
Price / Book1.94
Price / Tangible Book2.02
Debt / Equity0.28
Price / Sales1.00

Financial Strength

Altman Z-Score4.25
Piotroski F-Score 4 / 9
Beneish M-Score-0.87
Price to Intrinsic Value3.23
Price to Graham Number2.67
Shiller PE Ratio63.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.21% 26 / 100   
1 Month -16.79% 14 / 100   
2 Months -7.55% 50 / 100   
6 Months -25.76% 18 / 100   
1 Year -1.71% 70 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog